The size of the global hemodynamic monitoring systems market is estimated to value USD 1338 Million by 2027 from USD 1060 million in 2022, growing at a CAGR of 4.77% during the forecast period.
The hemodynamic monitoring system is used to measure blood pressure in veins, heart, and arteries, and it even measures blood flow and the presence of oxygen in the blood. A hemodynamic monitoring system is mostly used for patients suffering from cardiovascular health issues and needs to be assessed, especially cardiac surgery patients. Moreover, these tests observe the loss of cardiac functions such as decreased urine output, decreased cardiac output, gastrointestinal bleeding, cardiomyopathy, congestive heart failure, and myocardial infarction. In addition, these products further play the role of determining the blood volume and oxygen perfusion rate and restricts the incidence of adverse effects due to excess fluid administration. Therefore, the hemodynamic monitoring systems market is likely to grow steadily during the forecast year.
MARKET DRIVERS:
The market for hemodynamic monitoring devices is mainly driven due to an alarming rise in the prevalence of cardiovascular diseases, health conditions induced by sedentary lifestyles, the growing need for critical congenital heart disease (CCHD) screening, and the rising incidence of COPD other respiratory disorders. For instance, according to World Health Organization (WHO), in 2012, more than 17.5 million people were dead due to cardiovascular diseases. In addition, the rise in the elderly population and the adoption of sedentary lifestyles are boosting the market growth. Moreover, the increase in the number of surgeries year by year is propelling the market. In addition, the mounting incidence of chronic obstructive pulmonary disease (COPD) and other respiratory disorders fuel the hemodynamic monitoring systems market.
The growing need for critical congenital heart disease (CCHD) screening is a significant opportunity for market growth. The favorable reimbursement policies and the unhealthy diet in urban areas are estimated to fuel the market. Moreover, the rise in the investments in R&D by both government and private agents for effective treatment is boosting the global hemodynamic monitoring systems market.
MARKET RESTRAINTS:
The high costs associated with monitoring machines and the high price of treatments are the major restraints for market growth. In addition, the risk of thrombosis, air embolism, hemorrhage, sepsis, and bleeding associated with the invasive hemodynamic monitoring system is hampering the market growth. Furthermore, the lack of awareness among the people about disease diagnosis in emerging and underdeveloped countries is the major challenge for the market growth. Moreover, the lack of professional workers is preventing the hemodynamic monitoring systems market growth.
COVID-19 Impact on the global hemodynamic monitoring systems market:
The Global economy had adversely impacted during the pandemic. During a pandemic, all sectors got affected differently; some were positively impacted, and some were negatively impacted. The hemodynamic monitoring systems market had both positive and negative impacts. Due to the implementation of strict lockdown everywhere, the supply chain is disturbed, and the supply of raw material is affected, which impacted the market growth during the pandemic. But to treat COVID patients, all the non-ICU wards in hospitals had converted into intensive care units, which propelled the market during the pandemic. Since the corona patients need to be monitored thoroughly to avoid hemodynamic instability, the hemodynamic monitoring systems demand was raised. Moreover, several health authorities are approving the use of hemodynamic monitoring systems in corona patients. For example, for mechanical oxygenation and hemodynamic support, the FDA approved using the ECMO cannula system for better treatment. These agreements had raised the opportunity for the hemodynamic monitoring systems market during the pandemic. The key market players had led the hemodynamic monitoring systems market into profits in the rough times.
REPORT COVERAGE:
REPORT METRIC |
DETAILS |
Market Size Available |
2021 to 2027 |
Base Year |
2021 |
Forecast Period |
2022 to 2027 |
Segments Analysed |
By Product, Monitoring Type, End-User, and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
Regions Analysed |
North America, Europe, Asia Pacific, Latin America, Middle East, and Africa |
This research report on the global hemodynamic monitoring systems market has been segmented and sub-segmented based on the product, monitoring type, end-user, and region.
Hemodynamic Monitoring Systems Market – By Product:
The disposables segment is estimated to account for the largest share during the forecast period based on the product. The rising adoption of disposables in casualty rooms and critical care units in hospitals is driving the segment. Disposables are further segmented into sensors, guide wires, and measurement probes.
Hemodynamic Monitoring Systems Market - By monitoring type:
The invasive monitoring systems segment is estimated to account for the largest share based on the monitoring type. The early detection, identification, and treatment of life-threatening diseases are the main factors boosting the invasive monitoring systems segment. On the other hand, the minimally invasive market is gradually growing due to its ability to help in tracking stroke volume continuously.
Hemodynamic Monitoring Systems Market – By End User:
Based on end-users, the hospital's segment is estimated to account for the largest share. All of these three segments are projected to grow at the highest CAGR during the forecast period.
Hemodynamic Monitoring Systems Market – By Region:
Geographically, The hemodynamic monitoring systems market in North America is the biggest market in terms of market share globally. The market was estimated at USD 330.97 Million in 2020; and is projected to reach USD 411.99 Million by 2025, growing at a CAGR of 4.48% from 2020 to 2025. The rise in the aging population suffering from chronic diseases in North America contributes to market growth. In addition, the increase in acceptance of Hemodynamic Monitoring Systems in ICUs and casualty rooms is boosting the market. The US and Canada are the major market contributors in North America. Advancements in technology towards the monitoring systems are another notable factor helping the market's growth rate hike further. In 2016, Cheetah Medical Inc. got FDA approval for Starling SV, a non-invasive hemodynamic monitoring system. The presence of key players is fueling the North American Hemodynamic Monitoring Systems Market.
The hemodynamic monitoring systems market in Europe is the second-largest market in terms of market share. Europe was valued at USD 269.81 Million in 2020. It is projected to reach USD 331.93 Million at a CAGR of 4.23% by 2025. The European Heart Health Charter awareness programs helped the market grow. The UK market is anticipated to lead the European market during the forecast period. Germany was accounted for the second-largest share in the European market in 2019. The increase in the aging population diagnosed with various diseases put the European Hemodynamic Monitoring Systems Market second.
The Hemodynamic Monitoring Systems Market in the Asia-Pacific region is projected to grow at the highest CAGR, which is significant due to cardiovascular diseases and the increasing geriatric population. Brazil, India, China, with their economic growth, are the most potential markets.
The Hemodynamic Monitoring Systems Market in Latin America was worth USD 108.12 Million in 2021. It is further projected to reach USD 139.98 Million by 2026, growing at a CAGR of 5.3% from 2021 to 2026.
The hemodynamic monitoring systems market in the Middle East and Africa is mainly driven due to technological advancements, growth in the number of people suffering from hypertension, the growing diabetes population, and rapid growth in the aging population.
KEY MARKET PARTICIPANTS:
Companies leading the global hemodynamic monitoring systems market profiled in the report are Edwards Lifesciences Corporation, PULSION Medical Systems SE, LiDCO Group plc., Cheetah Medical Inc., Deltex Medical Group plc., Hemo Sapiens, Inc., ICU Medical, Inc., Osypka Medical GmbH, Schwarzer Cardiotek GmbH, and Tensys Medical, Inc.
RECENT MARKET DEVELOPMENTS:
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product Type
5.1.1 Introduction
5.1.2 Hemodymanic monitoring systems
5.1.3 Disposables
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Monitoring Type
5.2.1 Introduction
5.2.2 Invasive hemodynamic monitoring system
5.2.3 Minimally invasive hemodynamic monitoring system
5.2.4 Non-invasive hemodynamic monitoring system
5.2.5 Y-o-Y Growth Analysis, By Monitoring Type
5.2.6 Market Attractiveness Analysis,By Monitoring Type
5.2.7 Market Share Analysis, By Monitoring Type
5.3 End Users
5.3.1 Introduction
5.3.2 Hospitals
5.3.3 Catheterization laboratories
5.3.4 Home and Ambulatory Care
5.3.7 Y-o-Y Growth Analysis, By End User
5.3.8 Market Attractiveness Analysis, By End User
5.3.9 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.4 Market Attractiveness Analysis
6.1.5 Market Share Analysis
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Edwards Lifesciences Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 PULSION Medical Systems SE
8.3 LiDCO Group plc.
8.4 Cheetah Medical Inc.
8.5 Deltex Medical Group plc.
8.6 Hemo Sapiens, Inc.
8.7 ICU Medical, Inc.
8.8 Osypka Medical GmbH
8.9 Schwarzer Cardiotek GmbH
8.10 Tensys Medical, Inc
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
11. Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.